Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04039243 · ClinicalTrials.gov registry record · NA

Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study

A NA study of Fear and Anxiety Disorder of Childhood, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04039243 is a NA study of Fear and Anxiety Disorder of Childhood that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 90 participants, below the 256-participant average among 8 other Fear trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04039243, a NA study of Fear and Anxiety Disorder of Childhood, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the feasibility and efficacy of intervening with 2-year-old children with elevated temperamental Fear and/or Shyness or 3-year-old children with elevated anxiety and their parents, using a parent-child Cognitive Behavioral Therapy (CBT) protocol to reduce anxiety disorders and maintain reduced anxiety at one-year follow-up. Before the COVID-19 pandemic, study visits and treatment sessions were conducted in office. Now all visits and treatment sessions are conducted remotely.

Interventions

  • BEHAVIORAL Being Brave
  • OTHER Parent Education

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2019-09-27
Est. Completion 2026-06-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04039243

The ClinicalTrials.gov registry entry for NCT04039243 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 256-participant average among 8 other Fear trials with a reported enrollment target (65% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Fear appearing as the primary indexed condition, and to 2 interventions - of which Being Brave is the first listed.

NCT04039243 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04039243 about?

NCT04039243 is a clinical study titled "Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study". The purpose of this study is to test the feasibility and efficacy of intervening with 2-year-old children with elevated temperamental Fear and/or Shyness or 3-year-old children with elevated anxiety and their parents, using a parent-child Cognitive Behavioral Therapy (CBT) protocol to reduce anxiety...

What is the current status of trial NCT04039243?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2019-09-27. Estimated completion is 2026-06-01.

What conditions does trial NCT04039243 study?

This clinical trial studies the following conditions: Fear, Anxiety Disorder of Childhood, Shyness.

What interventions are being tested in trial NCT04039243?

The interventions under investigation include: Being Brave (BEHAVIORAL), Parent Education (OTHER).

Who is sponsoring clinical trial NCT04039243?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04039243 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.